Articles Posted in Mass Torts

The Cartiva toe implant is a synthetic cartilage device used to treat arthritis in the big toe. New evidence suggests that these implants are defectively designed and prone to failures that can result in pain, further surgery, and other injuries. Cartiva toe implant lawsuits are now being filed by individuals who experienced a premature failure of their implant.

We hoped to see Cartiva settlement payouts by 2025 as part of a global settlement. That has not happened. Unfortunately, this litigation is dragging on. But these lawsuits could reach a settlement at any time. You want to submit a case before that happens. So, if you have a claim, call us or another lawyer sooner rather than later.

Not many of these lawsuits have been filed.   But there are many more cases out there, and that is likely to change if there is no settlement soon. If you have a potential claim, call us today at 800-553-8082 or get a free consultation online.

For sickle cell patients and families, Oxbryta was supposed to be a lifeline. Instead, it left many worse off–facing new health crises, hospitalizations, and in some cases, unthinkable loss. Now, Oxbryta lawsuits are uncovering what Pfizer knew and when it knew it.

Oxbryta is a prescription drug developed by Global Blood Therapeutics and later acquired by Pfizer. It was voluntarily recalled in September 2024 after new evidence revealed that it caused serious and potentially fatal complications, including vaso-occlusive crises and organ damage.

This page looks at Oxbryta lawsuits and their potential settlement value.

Oxbryta is a prescription drug made by Pfizer that was recalled in September 2024 after evidence revealed that it caused a number of very serious and potentially fatal health problems, including vaso-occlusive crisis and organ damage. Continue reading

Our firm’s national mass tort lawyers continuously monitor and track events in the various class action MDLs pending in the federal courts (MDL Docket #s). We track the volume of new cases being filed or transferred into each MDL every month, the trends or patterns in new case filings, and the status of bellwether trials, discovery, and other proceedings. And, of course, we track mass tort settlement amounts.

With a new year, we are starting to get a clearer picture of what we can expect in 2025 from the various mass tort MDLs, including those ready to grow and those ready to settle.

This post examines the hottest, biggest, and most compelling mass torts in 2025 (and 2026 as we have started but not finished the work of updating these pages)  If you click the individual links, we also project these settlement amounts.

Our law firm represents individuals across the United States who have suffered serious burn injuries caused by defective pressure cookers, including the widely sold Ninja Foodi. These are not isolated incidents—these are preventable product failures that have left families scarred, physically and emotionally. For years, we have been filing lawsuits for victims injured by these dangerously flawed kitchen appliances.

These already strong pressure cooker lawsuits have grown even stronger: a recall has been issued for specific Ninja Foodi pressure cooker models. This recall confirms what many injured consumers and our lawyers have been saying all along. The product is defective and unreasonably dangerous. It should never have been sold in its current form.

Call us now at 800-553-8082 to speak directly with a lawyer, or complete our online contact form. We are ready to help you get answers, hold the manufacturer responsible, and fight for the settlement compensation you deserve.

This page is about Truvada lawsuits and other HIV drug injury lawsuits involving kidney or bone injuries.

HIV drugs containing tenofovir disoproxil fumarate (TDF) are, we believe, putting patients at risk. This has resulted in HIV drug lawsuits from victims alleging kidney disease and failure, bone density loss, bone injuries, and other side effects.

Viread® and Truvada® are two of the first brand-name drugs developed by Gilead Sciences to treat HIV. Viread and Truvada both use tenofovir disoproxil fumarate (TDF), a new type of antiviral drug that was one of the first effective treatments for slowing HIV.

This page is for parents looking to bring a WanaBana lawsuit on behalf of their child and their family for lead poisoning from this product.

Parents are angry and frustrated and want answers.  This page provides answers for victims wondering what to do and how to seek settlement compensation. Our lawyers also provide the most recent information on the recall and the developments in the litigation, including the bankruptcy which may kill this litigation.

Continue reading

This page is about the Valsartan lawsuits that are finally heading towards a trial in 2025.

Valsartan is a popular blood-pressure drug used by millions of people in the U.S. and sold under the brand names Diofan and Exforge. But Valsartan was recalled after it was discovered that the drug was contaminated with dangerously high levels of a carcinogenic chemical called NDMA. Continue reading

You may be here because you or someone in your family is dealing with a diagnosis like acute myeloid leukemia or another blood cancer. These conditions are devastating on their own. When they are linked to toxic chemicals like benzene, the frustration is even greater.

Benzene has been tied to cancer for decades. The research is clear. Workers have brought benzene exposure lawsuits across the country, and juries have awarded significant verdicts in many cases. Families have negotiated benzene lawsuit settlements after showing that their exposure on the job or in the community caused leukemia, multiple myeloma, or other blood-related diseases.

If you are considering a benzene lawsuit, you are likely wondering how the process works, whether your case qualifies, and what kind of compensation is possible. The answers are specific to your situation, but the starting point is always the same: understanding how exposure happens and how the law allows victims to bring claims.